Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction

被引:223
作者
Wang, Thomas J. [1 ]
机构
[1] Harvard Univ, Div Cardiol, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
关键词
genetics; imaging; prevention; prognosis; C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; BRAIN NATRIURETIC PEPTIDE; ARTERY CALCIUM SCORE; CLINICAL-TRIAL DESIGNS; ALL-CAUSE MORTALITY; MIDDLE-AGED MEN; ENDOTHELIAL DYSFUNCTION; MULTIPLE BIOMARKERS;
D O I
10.1161/CIRCULATIONAHA.109.912568
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:551 / 565
页数:15
相关论文
共 121 条
[1]   QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY [J].
AGATSTON, AS ;
JANOWITZ, WR ;
HILDNER, FJ ;
ZUSMER, NR ;
VIAMONTE, M ;
DETRANO, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) :827-832
[2]   Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events - The St. Francis Heart Study [J].
Arad, Y ;
Goodman, KJ ;
Roth, M ;
Newstein, D ;
Guerci, AD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :158-165
[3]   Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].
Atkinson, AJ ;
Colburn, WA ;
DeGruttola, VG ;
DeMets, DL ;
Downing, GJ ;
Hoth, DF ;
Oates, JA ;
Peck, CC ;
Schooley, RT ;
Spilker, BA ;
Woodcock, J ;
Zeger, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95
[4]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[5]   N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease [J].
Bibbins-Domingo, Kirsten ;
Gupta, Reena ;
Na, Beeya ;
Wu, Alan H. B. ;
Schiller, Nelson B. ;
Whooley, Mary A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02) :169-176
[6]   Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project [J].
Blankenberg, Stefan ;
Zeller, Tanja ;
Saarela, Olli ;
Havulinna, Aki S. ;
Kee, Frank ;
Tunstall-Pedoe, Hugh ;
Kuulasmaa, Kari ;
Yarnell, John ;
Schnabel, Renate B. ;
Wild, Philipp S. ;
Muenzel, Thomas ;
Lackner, Karl J. ;
Tiret, Laurence ;
Evans, Alun ;
Salomaa, Veikko .
CIRCULATION, 2010, 121 (22) :2388-U57
[7]   Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study [J].
Blankenberg, Stefan ;
McQueen, Matthew J. ;
Smieja, Marek ;
Pogue, Janice ;
Balion, Cynthia ;
Lonn, Eva ;
Rupprecht, Hans J. ;
Bickel, Christoph ;
Tiret, Laurence ;
Cambien, Francois ;
Gerstein, Hertzel ;
Muenzel, Thomas ;
Yusuf, Salim .
CIRCULATION, 2006, 114 (03) :201-208
[8]   Carotid intima-media thickness measurements in intervention studies - Design options, progression rates, and sample size considerations: A point of view [J].
Bots, ML ;
Evans, GW ;
Riley, WA ;
Grobbee, DE .
STROKE, 2003, 34 (12) :2985-2994
[9]   Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease - Additive value of flow-mediated dilation to ankle-brachial pressure index [J].
Brevetti, G ;
Silvestro, A ;
Schiano, V ;
Chiariello, M .
CIRCULATION, 2003, 108 (17) :2093-2098
[10]   C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the US Preventive Services Task Force [J].
Buckley, David I. ;
Fu, Rongwei ;
Freeman, Michele ;
Rogers, Kevin ;
Helfand, Mark .
ANNALS OF INTERNAL MEDICINE, 2009, 151 (07) :483-W161